Evidence-based quality indicators for the management of stage I–III NSCLC were identified.
The use of the PET-CT and invasive endoscopic techniques are process indicators.
The use of cytology in combination with histology during bronchoscopy is a process indicator.
The use of preoperative chemoradiation for clinical stage III NSCLC is a process indicator.
The use of postoperative chemotherapy for stage II/III NSCLC is a process indicator.